Skip to main content
. 2020 Oct 6;3:100091. doi: 10.1016/j.ajpc.2020.100091

Table 2.

LDL cholesterol in evolocumab treated patients stratified by baseline hsCRP.

hsCRP
P value
<1 ​mg/L [n ​= ​132] 1 – 3 ​mg/L [n ​= ​170] >3 ​mg/L [n ​= ​111]
Baseline, mg/dL ​± ​SD 90.1 ​± ​24.7 92.7 ​± ​28.6 92.7 ​± ​27.9 0.65
Weighted average, mg/dL ​± ​SD 32.1 ​± ​19.9 37.3 ​± ​25.1 35.9 ​± ​19.7 0.12
Absolute Change, % ​± ​SD −58.0 ​± ​22.8 −55.4 ​± ​30.7 −56.8 ​± ​21.3 0.69